Skip to main content
Erschienen in: International Orthopaedics 2/2019

11.08.2018 | Original Paper

Curettage, phenolization, and cementation in paediatric Ewing’s sarcoma with a complete radiological response to neoadjuvant chemotherapy

verfasst von: Khodamorad Jamshidi, Mehdi Ramezan Shirazi, Abolfazl Bagherifard, Alireza Mirzaei

Erschienen in: International Orthopaedics | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Although wide resection is the standard treatment for Ewing’s sarcoma (ES), it has complications especially in children. In this study, we compared the oncologic and functional outcomes of wide resection with extended curettage and local adjuvant therapy (phenolization and cementation), as a less extensive surgery for paediatric ES with a complete radiologic response to neoadjuvant chemotherapy.

Methods

Children aged ≤ ten years, with ES of non-expendable long-bones and complete radiologic response to neoadjuvant chemotherapy, were included in this case-control study. Twenty-six patients were treated with extended curettage and local adjuvant therapy (case group) and 17 were managed with wide resection (control group). The average follow-up period was 60.1 ± 28.7 months (range 30–168 months). Functional outcome was assessed with the Musculoskeletal Tumor Society (MSTS) scoring system.

Results

Three local recurrences (11.5%) and three distant metastases (11.5%) were observed in the case group. Two local recurrences (11.7%) and two metastases (11.7%) were recorded in the control group. The rate of local recurrence was not statistically different between the two study groups (p = 0.668). The rate of metastasis was not statistically different between the two study groups as well (p = 0.668). The complication rates were 15% in the case group and 53% in the control group (p = 0.005). The mean MSTS score was 98.3% and 74% in the case and control group, respectively (p < 0.001).

Conclusion

The oncologic outcome of extended curettage and local adjuvant therapy in paediatric ES with complete radiological response to neoadjuvant chemotherapy is comparable to wide resection, yet it offers considerably better functional results.
Literatur
1.
Zurück zum Zitat Ewing J (1921) Diffuse endothelioma of bone. Proc New York Path 21:17–24 Ewing J (1921) Diffuse endothelioma of bone. Proc New York Path 21:17–24
2.
Zurück zum Zitat Abdel-Mota’al MM, Katchy K, Mallur A, Ahmad F, El-Alfy B (2008) Management of unicameral bone cyst of proximal femur: experience of 14 cases and review of literature. Kuwait Med J 40:202–210 Abdel-Mota’al MM, Katchy K, Mallur A, Ahmad F, El-Alfy B (2008) Management of unicameral bone cyst of proximal femur: experience of 14 cases and review of literature. Kuwait Med J 40:202–210
3.
Zurück zum Zitat Canale ST, Beaty JH (2012) Campbell’s operative orthopaedics. Elsevier/Mosby, Philadelphia, PA Canale ST, Beaty JH (2012) Campbell’s operative orthopaedics. Elsevier/Mosby, Philadelphia, PA
5.
Zurück zum Zitat LaRue SM, Wrigley RH, Powers B (1987) A review of the effects of radiation therapy on bone. Vet Radiol Ultrasound 28(1):17–22CrossRef LaRue SM, Wrigley RH, Powers B (1987) A review of the effects of radiation therapy on bone. Vet Radiol Ultrasound 28(1):17–22CrossRef
6.
Zurück zum Zitat Cao X, Wu X, Frassica D, Yu B, Pang L, Xian L, Wan M, Lei W, Armour M, Tryggestad E (2011) Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells. Proc Natl Acad Sci 108(4):1609–1614CrossRefPubMed Cao X, Wu X, Frassica D, Yu B, Pang L, Xian L, Wan M, Lei W, Armour M, Tryggestad E (2011) Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells. Proc Natl Acad Sci 108(4):1609–1614CrossRefPubMed
7.
Zurück zum Zitat Scurr M, Judson I (2006) How to treat the Ewing’s family of sarcomas in adult patients. Oncologist 11(1):65–72CrossRefPubMed Scurr M, Judson I (2006) How to treat the Ewing’s family of sarcomas in adult patients. Oncologist 11(1):65–72CrossRefPubMed
8.
Zurück zum Zitat Obata H, Ueda T, Kawai A, Ishii T, Ozaki T, Abe S, Tanaka K, Tsuchiya H, Matsumine A, Yabe H (2007) Clinical outcome of patients with Ewing sarcoma family of tumors of bone in Japan. Cancer 109(4):767–775CrossRefPubMed Obata H, Ueda T, Kawai A, Ishii T, Ozaki T, Abe S, Tanaka K, Tsuchiya H, Matsumine A, Yabe H (2007) Clinical outcome of patients with Ewing sarcoma family of tumors of bone in Japan. Cancer 109(4):767–775CrossRefPubMed
9.
Zurück zum Zitat Verma V, Denniston KA, Lin CJ, Lin C (2017) A comparison of pediatric vs. adult patients with the Ewing sarcoma family of tumors. Front Oncol 7 Verma V, Denniston KA, Lin CJ, Lin C (2017) A comparison of pediatric vs. adult patients with the Ewing sarcoma family of tumors. Front Oncol 7
10.
Zurück zum Zitat Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley M-C, Kovar H, Grimer R, Whelan J, Claude L (2015) Ewing sarcoma: current management and future approaches through collaboration. J Clin Oncol 33(27):3036–3046CrossRef Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley M-C, Kovar H, Grimer R, Whelan J, Claude L (2015) Ewing sarcoma: current management and future approaches through collaboration. J Clin Oncol 33(27):3036–3046CrossRef
11.
Zurück zum Zitat Aghighi M, Boe J, Rosenberg J, Von Eyben R, Gawande RS, Petit P, Sethi TK, Sharib J, Marina NM, DuBois SG (2016) Three-dimensional radiologic assessment of chemotherapy response in Ewing sarcoma can be used to predict clinical outcome. Radiology 280(3):905–915CrossRefPubMedPubMedCentral Aghighi M, Boe J, Rosenberg J, Von Eyben R, Gawande RS, Petit P, Sethi TK, Sharib J, Marina NM, DuBois SG (2016) Three-dimensional radiologic assessment of chemotherapy response in Ewing sarcoma can be used to predict clinical outcome. Radiology 280(3):905–915CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Oberlin O, Patte C, Demeocq F, Lacombe M, Brunat-Mentigny M, Demaille M-C, Tron P, Bui BNg, Lemerle J (1985) The response to initial chemotherapy as a prognostic factor in localized Ewing’s sarcoma. Eur J Cancer 21 (4):463–467 Oberlin O, Patte C, Demeocq F, Lacombe M, Brunat-Mentigny M, Demaille M-C, Tron P, Bui BNg, Lemerle J (1985) The response to initial chemotherapy as a prognostic factor in localized Ewing’s sarcoma. Eur J Cancer 21 (4):463–467
13.
Zurück zum Zitat Juergens C, Weston C, Lewis I, Whelan J, Paulussen M, Oberlin O, Michon J, Zoubek A, Juergens H, Craft A (2006) Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-EWING 99 clinical trial. Pediatr Blood Cancer 47(1):22–29CrossRefPubMed Juergens C, Weston C, Lewis I, Whelan J, Paulussen M, Oberlin O, Michon J, Zoubek A, Juergens H, Craft A (2006) Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-EWING 99 clinical trial. Pediatr Blood Cancer 47(1):22–29CrossRefPubMed
14.
Zurück zum Zitat Nishino M, Jagannathan JP, Ramaiya NH, Van den Abbeele AD (2010) Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know. Am J Roentgenol 195(2):281–289CrossRef Nishino M, Jagannathan JP, Ramaiya NH, Van den Abbeele AD (2010) Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know. Am J Roentgenol 195(2):281–289CrossRef
15.
Zurück zum Zitat Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92(3):205–216CrossRef Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92(3):205–216CrossRef
16.
Zurück zum Zitat Mittag F, Leichtle C, Kieckbusch I, Wolburg H, Rudert M, Kluba T, Leichtle U (2013) Cytotoxic effect and tissue penetration of phenol for adjuvant treatment of giant cell tumours. Oncol Lett 5(5):1595–1598CrossRefPubMedPubMedCentral Mittag F, Leichtle C, Kieckbusch I, Wolburg H, Rudert M, Kluba T, Leichtle U (2013) Cytotoxic effect and tissue penetration of phenol for adjuvant treatment of giant cell tumours. Oncol Lett 5(5):1595–1598CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Jamshidi K, Bahrabadi M, Mirzaei A (2017) Long-term results of osteoarticular allograft reconstruction in children with distal femoral bone tumors. Arch Bone Joint Surg 5(5):296PubMed Jamshidi K, Bahrabadi M, Mirzaei A (2017) Long-term results of osteoarticular allograft reconstruction in children with distal femoral bone tumors. Arch Bone Joint Surg 5(5):296PubMed
18.
Zurück zum Zitat Wunder JS, Paulian G, Huvos AG, Heller G, Meyers PA, Healey JH (1998) The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am 80(7):1020–1033CrossRefPubMed Wunder JS, Paulian G, Huvos AG, Heller G, Meyers PA, Healey JH (1998) The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am 80(7):1020–1033CrossRefPubMed
20.
Zurück zum Zitat Casey DA, Wexler LH, Merchant MS, Chou AJ, Merola PR, Price AP, Meyers PA (2009) Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience. Pediatr Blood Cancer 53(6):1029–1034CrossRefPubMed Casey DA, Wexler LH, Merchant MS, Chou AJ, Merola PR, Price AP, Meyers PA (2009) Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience. Pediatr Blood Cancer 53(6):1029–1034CrossRefPubMed
21.
Zurück zum Zitat Wagner LM, McAllister N, Goldsby RE, Rausen AR, McNall-Knapp RY, McCarville MB, Albritton K (2007) Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma. Pediatr Blood Cancer 48(2):132–139CrossRefPubMed Wagner LM, McAllister N, Goldsby RE, Rausen AR, McNall-Knapp RY, McCarville MB, Albritton K (2007) Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma. Pediatr Blood Cancer 48(2):132–139CrossRefPubMed
22.
Zurück zum Zitat Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergensg H (2006) Ewing’s sarcoma family of tumors: current management. Oncologist 11(5):503–519CrossRefPubMed Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergensg H (2006) Ewing’s sarcoma family of tumors: current management. Oncologist 11(5):503–519CrossRefPubMed
23.
Zurück zum Zitat Bellan DG, Jesus-Garcia Filho R, Garcia JG, de Toledo PM, Viola DCM, Schoedl MF, Petrilli AS (2012) Ewing’s sarcoma: epidemiology and prognosis for patients treated at the Pediatric Oncology Institute, IOP-GRAACC-UNIFESP. Rev Bras Ortop 47(4):446–450CrossRefPubMed Bellan DG, Jesus-Garcia Filho R, Garcia JG, de Toledo PM, Viola DCM, Schoedl MF, Petrilli AS (2012) Ewing’s sarcoma: epidemiology and prognosis for patients treated at the Pediatric Oncology Institute, IOP-GRAACC-UNIFESP. Rev Bras Ortop 47(4):446–450CrossRefPubMed
24.
Zurück zum Zitat Rastogi S, Kumar A, Gupta H, Khan SA, Bakhshi S (2010) Short-term followup after surgical treatment of Ewing’s sarcoma. Indian J Orthop 44(4):384CrossRefPubMedPubMedCentral Rastogi S, Kumar A, Gupta H, Khan SA, Bakhshi S (2010) Short-term followup after surgical treatment of Ewing’s sarcoma. Indian J Orthop 44(4):384CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Do Kim J, Kim TH, Chung SH (2013) Long-term results of Ewing’s sarcoma--in a single institution. J Cancer Ther 4(1):323CrossRef Do Kim J, Kim TH, Chung SH (2013) Long-term results of Ewing’s sarcoma--in a single institution. J Cancer Ther 4(1):323CrossRef
26.
Zurück zum Zitat Bacci G, Ferrari S, Longhi A, Donati D, De Paolis M, Forni C, Versari M, Setola E, Briccoli A, Barbieri E (2003) Therapy and survival after recurrence of Ewing’s tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. Ann Oncol 14(11):1654–1659CrossRefPubMed Bacci G, Ferrari S, Longhi A, Donati D, De Paolis M, Forni C, Versari M, Setola E, Briccoli A, Barbieri E (2003) Therapy and survival after recurrence of Ewing’s tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. Ann Oncol 14(11):1654–1659CrossRefPubMed
27.
Zurück zum Zitat Albergo J, Gaston C, Laitinen M, Darbyshire A, Jeys L, Sumathi V, Parry M, Peake D, Carter S, Tillman R (2016) Ewing’s sarcoma. Bone Joint J 98(8):1138–1144CrossRefPubMed Albergo J, Gaston C, Laitinen M, Darbyshire A, Jeys L, Sumathi V, Parry M, Peake D, Carter S, Tillman R (2016) Ewing’s sarcoma. Bone Joint J 98(8):1138–1144CrossRefPubMed
28.
Zurück zum Zitat Kadhim M, Womer RB, Dormans JP (2017) Surgical treatment of pelvic sarcoma in children: outcomes for twenty six patients. Int Orthop 41(10):2149–2159CrossRefPubMed Kadhim M, Womer RB, Dormans JP (2017) Surgical treatment of pelvic sarcoma in children: outcomes for twenty six patients. Int Orthop 41(10):2149–2159CrossRefPubMed
29.
Zurück zum Zitat McCarville MB (2009) PET-CT imaging in pediatric oncology. Cancer Imag 9(1):35CrossRef McCarville MB (2009) PET-CT imaging in pediatric oncology. Cancer Imag 9(1):35CrossRef
Metadaten
Titel
Curettage, phenolization, and cementation in paediatric Ewing’s sarcoma with a complete radiological response to neoadjuvant chemotherapy
verfasst von
Khodamorad Jamshidi
Mehdi Ramezan Shirazi
Abolfazl Bagherifard
Alireza Mirzaei
Publikationsdatum
11.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
International Orthopaedics / Ausgabe 2/2019
Print ISSN: 0341-2695
Elektronische ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-018-4094-5

Weitere Artikel der Ausgabe 2/2019

International Orthopaedics 2/2019 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.